COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?

Subjects

Subjects :

2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Endocrinology, Diabetes and Metabolism
Angiotensin-Converting Enzyme Inhibitors
Severity of Illness Index
Renin-Angiotensin System
Angiotensin Receptor Antagonists
Risk Factors
Internal medicine
Renin–angiotensin system
Severity of illness
Internal Medicine
Prevalence
Medicine
Humans
Antihypertensive Agents
Respiratory Distress Syndrome
business.industry
SARS-CoV-2
COVID-19
Respiration, Artificial
Shock, Septic
Hospitalization
Intensive Care Units
Hypertension complications
Shock (circulatory)
Hypertension
Cardiology
Commentary
medicine.symptom
business
Cardiology and Cardiovascular Medicine
Respiratory Insufficiency
COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors

Details

ISSN :

17517176

Volume :

22

Issue :

11

Database :

OpenAIRE

Journal :

Journal of clinical hypertension (Greenwich, Conn.)

Accession number :

edsair.doi.dedup.....6a0ac8125ea367a9106d9ed0660bc723